Patient value: Perspectives from the advocacy community.
Addario BJ, Fadich A, Fox J, Krebs L, Maskens D, Oliver K, Schwartz E, Spurrier-Bernard G, Turnham T. […]
Adjuvant vascular endothelial growth factor (VEGF) targeted therapy in renal cell carcinoma: a systematic review and pooled-analysis.
Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas N, Harshman L, Quinn D, Larkin J, Pal S, Powles T, Ryan C , Sternberg C, Uzzo R, Choueiri T , Bex A. […]
An interdisciplinary consensus on the management of bone metastases from renal cell carcinoma.
Grünwald V, Eberhardt B, Bex A, Flörcken A, Gauler T, Derlin T, Panzica M, Dürr HR, Grötz KA,Giles RH, Falck Cv, Graser A, Muacevic A, Staehler M. […]
Publications
As a global network, the IKCC is committed to addressing unmet needs for kidney cancer patients worldwide and to promoting evidence-based guidelines and quality care. […]
How do I find out more about clinical trials?
There is a lot of useful information about clinical trials available online and through kidney cancer patient organisations. The IKCC Clinical Trials database can be used to search for kidney cancer clinical trials in your country and is updated automatically [...]
What are the risks and benefits of taking part in a trial?
When deciding if you want to take part in a trial, it is important to realise that the new treatment might work for you, but it might not. Depending upon the trial, you might be randomised to a control arm [...]